Open | - |
Close | - |
Volume / Avg. | 4.000 / 163.172K |
Day Range | - - - |
52 Wk Range | 11.850 - 59.975 |
Market Cap | $722.417M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 62 |
Short Interest | 2.64% |
Days to Cover | 3.02 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Praxis Precision Medicine (NASDAQ: PRAX) through any online brokerage.
Other companies in Praxis Precision Medicine’s space includes: Cabaletta Bio (NASDAQ:CABA), Cogent Biosciences (NASDAQ:COGT), Fusion Pharmaceuticals (NASDAQ:FUSN), Pharming (NASDAQ:PHAR) and Fate Therapeutics (NASDAQ:FATE).
The latest price target for Praxis Precision Medicine (NASDAQ: PRAX) was reported by HC Wainwright & Co. on Wednesday, March 6, 2024. The analyst firm set a price target for 105.00 expecting PRAX to rise to within 12 months (a possible 92.41% upside). 15 analyst firms have reported ratings in the last year.
The stock price for Praxis Precision Medicine (NASDAQ: PRAX) is $54.57 last updated March 18, 2024 at 4:16 PM EDT.
There are no upcoming dividends for Praxis Precision Medicine.
Praxis Precision Medicine’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for Praxis Precision Medicine.
Praxis Precision Medicine is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.